Clinical Trials Logo

Clinical Trial Summary

This study aims to evaluate the outcomes of a rural-DOC Pilot clinic which will be established in the Huntsville site of Muskoka Algonquin Healthcare. Patients from the Muskoka region who are confirmed to have a low-risk penicillin allergy are eligible for participation in the DOC clinic. Following their experience with the DOC, participation in this study will be voluntary and feedback will be requested from each participant, and local primary care providers. The feedback will be used to assess the impact of the DOC clinic on participants and the medical community over the 2 - year study. Feedback will also be collected to investigate ongoing antimicrobial use for those participants who were successfully delabeled. This will be accomplished by surveying participants at six and twelve months after their DOC.


Clinical Trial Description

Penicillin has a well-established role in treating clinical infections in humans and animals. It was the first antibiotic to be mass produced and is still used worldwide. Modifications to the penicillin molecule have yielded derivatives with activity against a broader range of bacteria. However, one of the major limitations to use of penicillin is the incidence of allergic reactions to the drug. Penicillin allergies are reported in more than 10% of outpatients and 15% of inpatients. However, more than 30% of patients have no recollection of the symptoms of their adverse reaction to a medication and the inaccurate or inadequate documentation of adverse reactions can lead to misunderstood allergies. This study will challenge low risk participants to determine if they can safely take penicillin ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06192277
Study type Interventional
Source Northern Ontario School of Medicine
Contact Maggie Partya-Sitnik, BA
Phone 705-789-0022
Email magdalena.sitnik@mahc.ca
Status Recruiting
Phase N/A
Start date October 6, 2023
Completion date December 15, 2024

See also
  Status Clinical Trial Phase
Completed NCT04513938 - Interest of the Second Phase of the Oral Challenge Test in Patients With Suspected Long-standing Penicillin Allergy
Recruiting NCT06112470 - Alleged Drug Allergies in Military General Medicine: Patients' Experiences and Beliefs